Alpha Teknova Grows Revenue 7% to $40.5M, Guides $42–44M in 2026
Alpha Teknova delivered $40.5 million in 2025 revenue, up 7% year-over-year, with fourth-quarter revenue of $10.0 million, an 8% increase. It forecasts $42–44 million in 2026 revenue and aims to achieve adjusted EBITDA positivity by end-2027 with free cash outflow under $10 million.
1. Strong Full-Year and Fourth-Quarter Revenue Growth
Alpha Teknova posted full-year 2025 revenue of $40.5 million, a 7% increase from $37.7 million in 2024. Fourth-quarter revenue rose 8% to $10.0 million versus $9.3 million a year earlier.
2. Segment Performance Drivers
Lab Essentials generated $31.0 million in 2025, up from $28.9 million in 2024. Clinical Solutions revenue climbed 47% in Q4 to $2.7 million and reached $7.65 million for the year, supported by a 25% increase in customer count.
3. Margin Expansion and Cash Flow Improvement
Gross margin expanded to 32.5% in Q4 from 23.0% a year ago, driven by higher Clinical Solutions mix and manufacturing efficiencies. Free cash flow improved to negative $9.8 million in 2025 from negative $13.5 million, with operating cash use declining to $8.6 million.
4. 2026 Guidance and Profitability Path
Management projects 2026 revenue of $42–44 million and free cash outflow below $10 million, reflecting increased commercial investment. The company targets adjusted EBITDA profitability by the end of 2027 as recent capital expenditures begin to drive returns.